Health THE U.S. FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI’S BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY July 5, 2022
Tech The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NFLX, AXSM and CDNA July 5, 2022
Biotechnology LAWSUITS FILED AGAINST ARQQ, OSCR and AXSM – Jakubowitz Law Pursues Shareholders Claims July 5, 2022
ASEP-PR-4 Asep Medical Inc. Announces Appointment Of Dr. Robert E. W. Hancock As CEO And Chairman July 5, 2022